Filter

971 - 980 of 1,013 Results

  • SUD Treatment in Medicaid: Variation by Service Type, Demographics, States and Spending

    Issue Brief

    Substance use disorders contribute to a growing number of deaths, yet they often go undiagnosed and untreated. While nearly three-quarters of Medicaid enrollees with a diagnosed substance use disorder utilized some type of treatment service in 2020, medication treatment rates varied widely, being much lower for alcohol use disorder than opioid use disorder, and lower among Black enrollees and youth compared to their counterparts. Treatment rates varied considerably across states and average Medicaid spending for…

  • Explainer: How States Are Using Medicaid Waivers to Help Incarcerated Individuals Get Care and Transition Back into Their Communities 

    News Release

    Compared to the general population, individuals who are incarcerated have higher rates of mental illness, substance use disorder, and chronic disease. However, the federal “inmate exclusion” policy prohibits Medicaid coverage for people who are incarcerated (except for limited inpatient hospital services). When people leave incarceration, they are at greater risk of overdose death and suicide, as well as hospitalization and emergency department use.  In a new explainer, KFF examines a new waiver opportunity that allows…

  • Tennessee Plans to Share Data on Children with Disabilities with Immigration Authorities

    Policy Watch

    This policy watch discusses a recent Tennessee law that requires the sharing of data for applicants and/or enrollees for the state's public assistance programs who do not have a qualified immigration status with immigration authorities, including for those enrolled in the state's Children's Special Services program, which serves children with disabilities.

  • End of Pandemic-Era Policies in Medicaid Home- and Community-Based Services Could Challenge Family Caregivers and Enrollees

    News Release

    Family caregivers played a key role in supporting people who used Medicaid home- and community-based services (HCBS) during the COVID pandemic. Many states used new pandemic-era authorities to support and pay family caregivers and maintain services in other ways amid workforce shortages and other challenges. Now, several states are ending payments to family caregivers and unwinding other pandemic-era policies, which could complicate ongoing workforce shortages and create new challenges for enrollees, according to survey of…

  • Rapid Home Tests for COVID-19: Issues with Availability and Access in the U.S.

    Issue Brief

    In this brief, we examine the various interrelated factors that have contributed to rapid home test scarcity in the U.S. There are several interrelated factors that impact the availability of rapid home COVID-19 tests. These range from the regulatory environment to the supply chain to federal investment and messaging to affordability.

  • Understanding the Diversity in the Asian Immigrant Experience in the U.S.

    Poll Finding

    Asian immigrants represent an important significant and growing share of the U.S. population, as well as a diverse body of experiences. Increased data on Asian immigrant experiences is important for understanding their diversity of experiences and focusing initiatives, policies, and resources to address the challenges they face.

  • 3 Charts: Asian Immigrants’ Experiences in the United States

    News Release

    Like other immigrants to the U.S., Asian immigrants overwhelmingly say they emigrated for the opportunity to build a better life for themselves and their children. They come from more than 30 countries, and their experiences – their economic circumstance, how safe they feel, and the discrimination they face - vary greatly once here, including differences by income level, immigration status and country of origin. These three charts explore the diversity of the Asian immigrant experience,…

  • Medication Abortion in the Courts: What’s at Stake?

    News Release

    Access to medication abortion has emerged as a central issue following the Dobbs decision overturning Roe v. Wade. There is ongoing litigation in four federal cases about the FDA’s approval and regulation of mifepristone, one of the two drugs used in medication abortion. Mifepristone, approved by the FDA in 2000, has a long record of safety and effectiveness and has been used by more than 5 million people in the United States. In the most…